Valink Therapeutics

YC W21 · Active · Discovering bispecific antibody drug-conjugates (BsADC) against cancer

Competitors

Companies closest to Valink Therapeutics
Company	Category	Status	Program
Eris BiotechShared: drug discovery, therapeutics, biotechActiveOther	Other	Active	YCW24
Sequence BioShared: drug candidate, drug discovery, therapeuticsActiveOther	Other	Active	YCS19
AlixiaShared: drug discovery, therapeutics, biotechActiveOther	Other	Active	YCW22
Origami Therapeutics, Inc.Shared: drug discovery, therapeutics, biotechActiveOther	Other	Active	YCW22
Abalone BioShared: antibody drug, drug discovery, therapeuticsActiveAI	AI	Active	YCW20

Adjacent

Companies next to Valink Therapeutics
Company	Category	Status	Program
Velorum TherapeuticsShared: drug discovery, therapeutics, biotechActiveOther	Other	Active	YCW24
Guardian BioShared: against cancer, therapeutics, biotechActiveOther	Other	Active	YCS22
Gerostate AlphaShared: therapeutics, biotech, novelInactiveOther	Other	Inactive	YCS18
PipeBioShared: antibody drug, develop, processAcquiredAI	AI	Acquired	YCW21
ParcelBioShared: drug discovery, therapeutics, biotechActiveOther	Other	Active	YCW24

Also from W21

All of W21

Company	Category	Status
AbacumThe AI-native FP&A platform that helps Finance teams drive business…ActiveAI	AI	Active
AlineaAutomated investing for the next generation 💸ActiveAI	AI	Active
AlokaiFrontend Platform for eCommerceActiveDevtools	Devtools	Active
AnimaThe next generation care enablement platformActiveAI	AI	Active
arnataAI workers for the logistics industry.ActiveAI	AI	Active
ArpioRecover from any outage in 10 minutes or less.ActiveDevtools	Devtools	Active

About Valink Therapeutics

Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.

YC batch: W21 · Winter 2021
Status, per YC: Active
Category: Other
Team size: 15
Location: Boston, MA, USA
Checked: 36m ago

YC tags: Biotech, Therapeutics, Drug discovery

Valink Therapeutics in W21: 336 companies, 30% AI

Valink Therapeutics: questions

Which YC batch was Valink Therapeutics in?

Valink Therapeutics was in Y Combinator's Winter 2021 batch (W21).

Is Valink Therapeutics still active?

Y Combinator lists Valink Therapeutics as active.

Where is Valink Therapeutics based?

Valink Therapeutics lists Boston, MA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.